Edward M Kerwin Selected Research

Salmeterol Xinafoate (Serevent)

8/2022	Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD.
1/2021	Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial.
1/2021	Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial.
1/2020	Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma.
1/2020	Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial.
10/2019	Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward M Kerwin Research Topics

Disease

42	Chronic Obstructive Pulmonary Disease (COPD) 08/2022 - 10/2007
17	Asthma (Bronchial Asthma) 06/2021 - 04/2008
6	Dyspnea (Shortness of Breath) 01/2021 - 12/2012
2	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2019 - 06/2018
1	Inflammation (Inflammations) 01/2021
1	Tremor (Tremors) 01/2021
1	Airway Remodeling 01/2020
1	Lung Diseases (Lung Disease) 01/2019
1	Constipation 04/2012

Drug/Important Bio-Agent (IBA)

14	Bronchodilator Agents (Bronchodilators)IBA 08/2022 - 12/2011
14	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 04/2008
13	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2020 - 01/2015
12	Formoterol Fumarate (Oxis)FDA Link 01/2020 - 10/2007
11	vilanterolIBA 08/2022 - 04/2013
9	GSK573719IBA 08/2022 - 01/2017
7	Muscarinic AntagonistsIBA 01/2019 - 10/2014
6	Salmeterol Xinafoate (Serevent)FDA Link 08/2022 - 10/2019
6	SuspensionsIBA 06/2021 - 01/2018
6	Tiotropium Bromide (Spiriva)FDA Link 01/2021 - 01/2015
5	Budesonide (Pulmicort)FDA LinkGeneric 01/2020 - 05/2008
5	SolutionsIBA 01/2020 - 10/2007
4	Albuterol (Salbutamol)FDA LinkGeneric 06/2021 - 01/2016
4	apaflurane (hydrofluoroalkane)IBA 01/2021 - 01/2016
3	aclidinium bromideIBA 01/2019 - 04/2012
3	fluticasone furoate FDA Link 09/2014 - 04/2013
3	indacaterolIBA 02/2013 - 12/2011
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021 - 01/2020
2	Fluticasone (Cutivate)FDA LinkGeneric 01/2020 - 01/2017
2	budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA 01/2020 - 07/2019
2	Beclomethasone (Beclometasone)FDA Link 01/2019 - 09/2016
2	AerosolsIBA 01/2018 - 01/2017
2	Procaterol (Pro-Air)IBA 01/2017 - 01/2016
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2015 - 04/2012
1	BromidesIBA 08/2022
1	ensifentrineIBA 01/2021
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2021
1	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2020
1	benralizumabIBA 01/2020
1	GoldIBA 07/2019
1	batefenterolIBA 01/2019
1	Pharmaceutical PreparationsIBA 06/2018
1	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 01/2018
1	vidupiprantIBA 02/2013
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 02/2013
1	ProstaglandinsIBA 02/2013
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 05/2008

Therapy/Procedure

16	Therapeutics 08/2022 - 07/2009
15	Metered Dose Inhalers (Metered Dose Inhaler) 01/2021 - 07/2009
10	Nebulizers and Vaporizers (Inhaler) 04/2020 - 10/2007
10	Dry Powder Inhalers 01/2020 - 10/2007
1	Drug Therapy (Chemotherapy) 01/2020